Creatine kinase isoforms as circulating markers of deterioration in idiopathic dilated cardiomyopathy

Clinical Cardiology

Volumn 20, Issue 1, 1997, Pages 55-60

  Hossein NlA, Mojgan ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

cardiac enzymes; dilated cardiomyopathy; myocardial damage

Indexed keywords

CREATINE KINASE;

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE CONTRACTILITY; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; VIRUS INFECTION;

EID: 0031021129     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960200112     Document Type: Article

References (36)

1. Fuster V, Gersh BJ, Giuliani ER, Tajik AJ, Brandenburg RO, Frye RL: The natural history of idiopathic dilated cardiomy opathy. Am J Cardiol 1981;47:525-531
2. Hofmann T, Meinertz T, Kasper W, Geibel A, Zehender M, Hohnloser S, Stienen U, Treese N, Just H: Mode of death in idiopathic dilated cardiomyopathy: A multivariate analysis of prognostic determinants. Am Heart J 1988;116:1455-1463
3. Brandenberg RO, Chazov E, Cherian G, Falase AO, Grosgogeat Y, Kawai C, Loogen F, Judez M, Orinius E, Goodwin G, Olsen EGJ, Oakley CM, Pisa Z: Report of the WHO/ISFC task force on definition and classification of the cardiomyopathies. Circulation 1981 ; 64:1397-1399
4. Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, Freeke CA, Archard LC: Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 1994;89(6):2582-2589
5. Neu N, Craig SW, Rose NR, Alvarez F, Beisel KW: Coxsackievirus induced myocarditis in mice: Cardiac myosin autoantibodies do not cross-react with the virus. Clin Exper Immun 1987;69: 566-574
6. Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri GO, Craig SW: Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987; 139:3630-3636
7. Neumann DA: Autoimmunity and idiopathic dilated cardiomyopathy. Mayo clin Proc 1994;69:193-195
8. Caforio ALP: Role of autoimmunity in dilated cardiomyopathy. Br Heart J 1994;72(suppl):S30-S34
9. Goldrach S, Haissaguerre M, Braustet JP: Prognostic value of the hemodynamic study at rest and during the exercise test in 103 cases of primary dilated cardiomyopathies. Arch Mal Coeur 1987;80: 1333-1340
10. Hagege A, Desnos M, Femandez F, Cristofmi P, Guenot O, Bourmayan C, Marcantoni JP, Guerot C: Prognostic factors in dilated cardiomyopathies. Arch Mol Coeur 1988;81:1473-1479
11. Saxon LA, Stevenson WG, Middlekauff HR, Fonarrow G, Woo M, Moser D, Stevenson LW: Predicting death from progressive heart failure secondary to ischémie or idiopathic dilated cardiomyopathy. AmJCardiol 1993;72:62-65
12. Komajda M, Jais JP, Goldfarb B, Bouhour JB, Juillieres Y, Lanfranchi J, Peycelon P, Geslin P, Carrie D, Grosgogeat Y: Analysis of predictive factors of mortality in dilated cardiomyopathy. A cooperative study by the Cardiomyopathy Working Group. Arch Mal Coeur 1990;83:899-906
13. Romeo F, Pelliccia F, Cianfrocca C, Gallo P, Barilla F, Cristofani R, Reale A: Determinants of end-stage idiopathic dilated cardiomyopathy: A multivariate analysis of 104 patients. Clin Cardiol 1989;12:387-392
14. Zanchetta M, Pedon L, Carton R, Franceschetto L, Maiolino P: Dilated cardiomyopathy: Multivariate discriminant analysis of main hemodynamic-angiographic indices. Giom Ital Cardiol 1990;20:15-19 (in Italian)
15. Fazio G, Veltri EP, Tomaselli G, Lewis R, Griffith LS, Guamieri T: Long-term follow-up of patients with nonischemic dilated cardiomyopathy and ventricular tachyarrhythmias treated with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 1991;14:1905-1910
16. Teragaki M, Ohmura T, lida H, Tahara A, Itagane H, Toda I, Akioka K, Yasuda M, Nishimoto M, Takeuchi K, TakedaT, Monta S, Tsukada H: Change of the isoform of crcatine phosphokinase MM in hypertrophie cardiomyopathy. Am Heart J 1993;125(1): 251-253
17. Wu AHB, Cornet TG, Wu VH, Brockie RE, Nishikawa A: Early diagnosis of acute myocardial infarction by rapid analysis of creatine kinase isoenzyme-3 (CK-MM) subtypes. Clin Cliem 1987; 33(3):358-362
18. Annesley TM, Strongwater SL, Schitzer TJ: MM subisoenzymes of creatine kinase as an index of disease activity in polymyositis. Clin Chem 1985;31:1162-1169
19. Hossein-Nia M, Kallis P, Brown PA, Chester MR, Kaski JC, Murday AJ, Treasure T, Holt DW: Creatine kinase MB isoforms: Sensitive markers of ischaemic myocardial damage. Clin Chem 1994;40(7):1265-1271
20. Puleo PR, Guadagno PA, Roberts R, Scheel MV, Marian AJ, Churchill D, Ferryman MB: Early diagnosis of myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation 1990;82:759-764
21. Manolio TA, Baughman KL, Rodeheffer R, Pearson TA, Bristow D, Michels VV, Abelmann WH, Harlan WR: Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of National Heart, Lung, and Blood Institute workshop). Am J Cardiol 1992; 69:1458-1466
22. Aretz HT, Billingham ME, Edwards VVD, Factor FM, Fallon JT, Fenolio JJ, Olsen EG, Schoen FJ: Myocarditis, a histopathologic definition and classification. AmJCanliovascPatholl981;1:3-l4
23. Greene HL, Richardson DW, Baker AH, Roden DM, Capone RJ, Echt DS, Friedman LM, Gillespie MJ, Hallstrom AP, Verier J: Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (The Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989;63:1-6
24. Henry WL, Gardin JM, Ware JH: Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980; 62(5): 1054-1061
25. Blackie SP, Fairbarn MS, McElvaney GN, Morrison NJ, Wilcox PG, Pardy RL: Prediction of maximal oxygen uptake and power during cycle ergometry in subjects older than 55 years of age. Am RevRespirDls 1989;139:1424-1429
26. Davies J, Reynolds T, Penney MD: Creatine kinase isoforms: .Investigation of inhibitors of in vitro degradation and establishment of a reference range. Ann Clin Biochem 1992;29:202-205
27. Wicks RW, Usategui-Gomez M, Miller M, Warshaw M: Immunochemical determination of CK-MB isoenzyme in human serum: II. An enzymatric approach. Clin Chem 1982;28:54-58
28. Puleo PR, Perryman MB, Bresser MA, Rokey R, Pratt CM, Roberts R: Creatine kinase isoform analysis in the detection and assessment of thrombolysis in man. Circulation 1987;5:1162-1169
29. Puleo PR, Guadagno PA, Roberts R, Perryman MB : Sensitive and rapid assay of plasma subforms of creatine kinase MB. Clin Chem 1989;35:1452-1455
30. Kanemitsu F, Okigaki T: Creatine kinase MB isoforms for early diagnosis and monitoring of acute myocardial infarction. Clin Chim Actol992;206:191-199
31. Kawai C, Matsumori A, Fujiwara H: Myocarditis and dilated cardiomyopathy. Ann Rev Med 1987;38(221):221-239
32. Caforio AL, Stewart JT, Bonifacio E, Burke M, Davies MJ, McKenna WJ, Bottazzo OF: Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J Autoimmun 1990;3(2): 187-200 '
33. Caforio AL, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo GF, McKenna WJ: Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 1990; 15(7):1527-1534
34. Caforio AL, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S: Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992;85(5): 1734-1742
35. Caforio A, Keeling P, Gordon D, Holt D, McKenna W: T-cell involvement in dilated cardiomyopathy: Interleukin-2 receptor levels are high and related to endomyocardial biopsy markers of immune activation (abstr). Circulation 1993;88:1833
36. Kuhl U, Daun B, Seeberg B, Schultheiss HP, Strauer BE: Dilated cardiomyopathy: A chronic myocarditis? Immunological characterisation of lymphocytic infiltrates. Herz 1992;17:97-106 .